Ads
related to: Libre Freestyle
Search results
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Zacks via Yahoo Finance· 10 hours agoStructural Heart sales rose 13%. Heart Failure sales improved 8.4% year over year organically. The...
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
Benzinga via Yahoo Finance· 10 hours agoReported sales increased by 2.2%, which includes the anticipated decline in COVID-19 testing-related...
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 hours agoWe believe this test has the potential to transform the standard of care for concussion testing, and...
Abbott's device sales drive profit beat, but shares fall as forecast disappoints
Reuters via AOL· 13 hours ago(Reuters) -Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday on...
Abbott Laboratories (ABT) Q1 Earnings: Surpasses EPS Estimates and Raises Full-Year Guidance
GuruFocus.com via Yahoo Finance· 12 hours agoFurthermore, the FDA approvals for TriClip and the i-STAT TBI test have broadened the company's portfolio in medical devices and diagnostics. Financial and Operational...
Abbott Labs' surprise guidance bump is a major positive for its shareholders
CNBC· 6 hours agoAbbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by...
Abbott looks to ‘highly productive’ device pipeline for future growth
MedTech Dive via Yahoo Finance· 13 hours agoCEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the...
Abbott stock slips despite Q1 beat (NYSE:ABT)
Seeking Alpha· 12 hours agoAbbott Laboratories (ABT) stock fell even as its Q1 2024 results exceeded estimates despite a contraction in its diagnostics division. Read more here.
5 stocks to watch on Wednesday: LLY, ABT and more
Seeking Alpha· 11 hours agoU.S. stock index futures on Wednesday were higher, pointing to a rebound from the previous session. Wall Street's rate cut expectations took another hit...
Abbott Labs Faces Downturn Post-Q1 Results Amid Mixed Sector Per
Guru Focus· 8 hours agoAbbott Labs (ABT) witnessed a decline of 3% in its stock following the announcement of its first-quarter results. This trend mirrors the reaction to Johnson & J
Ads
related to: Libre Freestyle
